CH Biotech R&D Co., Ltd. announced CHB resignation of Brent Randall Smith as Natural-person director, effective March 2, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
84 TWD | -0.24% |
|
-2.21% | +4.35% |
05-21 | Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members | CI |
05-21 | CH Biotech R&D Co., Ltd. Announces Audit Committee Changes | CI |
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.35% | 266M | |
+11.37% | 36.97B | |
-.--% | 11.74B | |
+25.10% | 7.75B | |
-10.21% | 7.05B | |
+7.53% | 6.88B | |
-9.96% | 5.59B | |
-11.32% | 5.24B | |
-2.86% | 5.14B | |
+28.14% | 5.03B |
- Stock Market
- Equities
- 6534 Stock
- News CH Biotech R&D Co., Ltd.
- CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director